Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations

Current dry powder formulations for inhalation deposit a large fraction of their emitted dose in the upper respiratory tract where they contribute to off-target adverse effects and variability in lung delivery. The purpose of the current study is to design a new formulation concept that more effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Danforth P. Miller, Thomas E. Tarara, Jeffry G. Weers
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Online Access:https://doaj.org/article/f88f6d36841c437f9e8e7cbd4ec111e4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items